5 Results for "

SHP099

" in MedChemExpress (MCE) Product Catalog:
Products (5)

5 Results for "SHP099" in MCE Product Catalog:

76
76 Cited Publications
Cat. No.: HY-100388
CAS No.: 1801747-42-1
Purity:  99.81%
Target:  

SHP2 Phosphatase

Research Areas:  

Cancer

SHP099 is an allosteric SHP2 inhibitor, with IC50s of 0.690, 1.241, 0.416, 1.968, 2.896 μM for SHP2, SHP2 D61Y, SHP2E69K, SHP2 A72V, SHP2 E76K. SHP099 inhibits cancer cell growth, such as MV4-11 and TF-1 cell (IC50: 0.32 and 1.73 μM). SHP099 inhibits RAS-ERK signaling and inhibits tumor growth .
loading...
    loading...
76
76 Cited Publications
Cat. No.: HY-100388A
CAS No.: 2200214-93-1
Purity:  99.87%
Target:  

SHP2 Phosphatase

Research Areas:  

Cancer

SHP099 hydrochloride is a potent, selective and orally available SHP2 inhibitor with an IC50 of 70 nM .
loading...
    loading...
Cat. No.: HY-100388AR
CAS No.: 2200214-93-1
Research Areas:  

Cancer

SHP099 (monohydrochloride) (Standard) is the analytical standard of SHP099 (monohydrochloride). This product is intended for research and analytical applications. SHP099 hydrochloride is a potent, selective and orally available SHP2 inhibitor with an IC50 of 70 nM .
loading...
    loading...
Cat. No.: HY-100388R
CAS No.: 1801747-42-1
Research Areas:  

Cancer

SHP099 (Standard) is the analytical standard of SHP099. This product is intended for research and analytical applications. SHP099 is an allosteric SHP2 inhibitor, with IC50s of 0.690, 1.241, 0.416, 1.968, 2.896 μM for SHP2, SHP2D61Y, SHP2E69K, SHP2A72V, SHP2E76K. SHP099 inhibits cancer cell growth, such as MV4-11 and TF-1 cell (IC50: 0.32 and 1.73 μM). SHP099 inhibits RAS-ERK signaling and inhibits tumor growth .
loading...
    loading...
Cat. No.: HY-184339
BRD4-IN-42 is a BRD4 BD1 inhibitor with an IC50 of 108.50 nM. BRD4-IN-42 can be used for the synthesis of PROTACs and serves as the target protein moiety of PROTAC BET Degrader-18 (HY-184335). BRD4-IN-42 inhibits the proliferation of wild-type and SHP099-resistant acute myeloid leukemia cells. BRD4-IN-42 is applicable to research related to acute myeloid leukemia .
loading...
    loading...